Skip to main content
Top
Published in: Metabolic Brain Disease 3/2018

01-06-2018 | Original Article

Zeaxanthin improved diabetes-induced anxiety and depression through inhibiting inflammation in hippocampus

Authors: Xiaoyan Zhou, Tian Gan, Gaoxia Fang, Shangshang Wang, Yizhen Mao, Changjiang Ying

Published in: Metabolic Brain Disease | Issue 3/2018

Login to get access

Abstract

It is generally accepted that inflammation plays a key role in anxiety and depression induced by diabetes. However, the underlying mechanism and effective treatment method of these diabetes-associated behavior disorders remain to be determined. In the present study, we attempted to illuminate the implication of zeaxanthin in anxiety, depression and neuroinflammation caused by hyperglycemia, and further elaborate the relevant mechanism under these neuropsychiatric disorders. In the current work, diabetic rats were induced by high glucose and fat diet followed by a single intraperitoneal injection of streptozocin, and zeaxanthin was orally administration every day (From 6th to 19th week). Diabetes-associated anxiety and depression were assessed using open field test (OFT) and Forced swimming test (FST) respectively. Moreover, the levels of interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in hippocampus were tested using ELISA and WB. Data showed that long-term zeaxanthin treatment improve diabetic symptoms and alleviate anxiety and depression in diabetic rats. Furthermore, excessive production of IL-6, IL-1β and TNF-α could be reduced with zeaxanthin treatment. In conclusion, we suggested that zeaxanthin can ameliorate diabetes-associated anxiety and depression, inhibit inflammation in diabetic rats. Our results could provide a potential therapeutic approach for the treatment of abnormal behavior induced by hyperglycemia.
Literature
go back to reference Aswar U, Chepurwar S, Shintre S, Aswar M (2017) Telmisartan attenuates diabetes induced depression in rats. Pharmacol Rep 69(2):358–364CrossRefPubMed Aswar U, Chepurwar S, Shintre S, Aswar M (2017) Telmisartan attenuates diabetes induced depression in rats. Pharmacol Rep 69(2):358–364CrossRefPubMed
go back to reference Black CN, Penninx BW, Bot M, Odegaard AO, Gross MD, Matthews KA et al (2016) Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study. Transl Psychiatry 6:e743CrossRefPubMedPubMedCentral Black CN, Penninx BW, Bot M, Odegaard AO, Gross MD, Matthews KA et al (2016) Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study. Transl Psychiatry 6:e743CrossRefPubMedPubMedCentral
go back to reference Bocco BM, Werneck-de-Castro JP, Oliveira KC, Fernandes GW, Fonseca TL, Nascimento BP et al (2016) Type 2 Deiodinase Disruption in Astrocytes Results in Anxiety-Depressive-Like Behavior in Male Mice. Endocrinology 157(9):3682–3695CrossRefPubMedPubMedCentral Bocco BM, Werneck-de-Castro JP, Oliveira KC, Fernandes GW, Fonseca TL, Nascimento BP et al (2016) Type 2 Deiodinase Disruption in Astrocytes Results in Anxiety-Depressive-Like Behavior in Male Mice. Endocrinology 157(9):3682–3695CrossRefPubMedPubMedCentral
go back to reference Doyle T, Halaris A, Rao M (2014) Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings. Curr Diab Rep 14(2):560CrossRefPubMed Doyle T, Halaris A, Rao M (2014) Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings. Curr Diab Rep 14(2):560CrossRefPubMed
go back to reference Johari N, Manaf ZA, Ibrahim N, Shahar S, Mustafa N (2016) Predictors of quality of life among hospitalized geriatric patients with diabetes mellitus upon discharge. Clin Interv Aging 11:1455–1461CrossRefPubMedPubMedCentral Johari N, Manaf ZA, Ibrahim N, Shahar S, Mustafa N (2016) Predictors of quality of life among hospitalized geriatric patients with diabetes mellitus upon discharge. Clin Interv Aging 11:1455–1461CrossRefPubMedPubMedCentral
go back to reference Johnson EJ (2014) Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev 72(9):605–612CrossRefPubMed Johnson EJ (2014) Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev 72(9):605–612CrossRefPubMed
go back to reference Kou L, Du M, Zhang C, Dai Z, Li X, Zhang B (2017) The Hypoglycemic, Hypolipidemic, and Anti-Diabetic Nephritic Activities of Zeaxanthin in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats. Appl Biochem Biotechnol 182(3):944–955CrossRefPubMed Kou L, Du M, Zhang C, Dai Z, Li X, Zhang B (2017) The Hypoglycemic, Hypolipidemic, and Anti-Diabetic Nephritic Activities of Zeaxanthin in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats. Appl Biochem Biotechnol 182(3):944–955CrossRefPubMed
go back to reference Kowluru RA, Zhong Q, Santos JM, Thandampallayam M, Putt D, Gierhart DL (2014) Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab (Lond) 11(1):8CrossRef Kowluru RA, Zhong Q, Santos JM, Thandampallayam M, Putt D, Gierhart DL (2014) Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab (Lond) 11(1):8CrossRef
go back to reference Laake JP, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC et al (2014) The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care 37(8):2186–2192CrossRefPubMed Laake JP, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC et al (2014) The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care 37(8):2186–2192CrossRefPubMed
go back to reference Masís-Calvo M, Sequeira-Cordero A, Mora-Gallegos A, Fornaguera-Trías J (2013) Behavioral and neurochemical characterization of maternal care effects on juvenile Sprague-Dawley rats. Physiol Behav 118:212–217CrossRefPubMed Masís-Calvo M, Sequeira-Cordero A, Mora-Gallegos A, Fornaguera-Trías J (2013) Behavioral and neurochemical characterization of maternal care effects on juvenile Sprague-Dawley rats. Physiol Behav 118:212–217CrossRefPubMed
go back to reference Neelam K, Goenadi CJ, Lun K, Yip CC, Au Eong KG (2017) Putative protective role of lutein and zeaxanthin in diabetic retinopathy. Br J Ophthalmol 101(5):551–558CrossRefPubMed Neelam K, Goenadi CJ, Lun K, Yip CC, Au Eong KG (2017) Putative protective role of lutein and zeaxanthin in diabetic retinopathy. Br J Ophthalmol 101(5):551–558CrossRefPubMed
go back to reference Patel SS, Udayabanu M (2014) Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis 29(1):121–130CrossRefPubMed Patel SS, Udayabanu M (2014) Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis 29(1):121–130CrossRefPubMed
go back to reference da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC (2016) Rizzo de Souza LE, et al. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes. Mol Neurobiol 53(10):6997–7009CrossRefPubMed da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC (2016) Rizzo de Souza LE, et al. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes. Mol Neurobiol 53(10):6997–7009CrossRefPubMed
go back to reference Sluijs I, Cadier E, Beulens JW (2015) van der A DL, Spijkerman AM, van der Schouw YT. Dietary intake of carotenoids and risk of type 2 diabetes. Nutr Metab Cardiovasc Dis 25(4):376–381CrossRefPubMed Sluijs I, Cadier E, Beulens JW (2015) van der A DL, Spijkerman AM, van der Schouw YT. Dietary intake of carotenoids and risk of type 2 diabetes. Nutr Metab Cardiovasc Dis 25(4):376–381CrossRefPubMed
go back to reference Song X, Liu B, Cui L, Zhou B, Liu W, Xu F (2017a) Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav 179:487–493CrossRefPubMed Song X, Liu B, Cui L, Zhou B, Liu W, Xu F (2017a) Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav 179:487–493CrossRefPubMed
go back to reference Song Y, Zhang F, Ying C, Kumar KA, Zhou X (2017b) Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia. Metab Brain Dis 32(5):1627–1637CrossRefPubMed Song Y, Zhang F, Ying C, Kumar KA, Zhou X (2017b) Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia. Metab Brain Dis 32(5):1627–1637CrossRefPubMed
go back to reference Stringham NT, Holmes PV, Stringham JM (2017) Supplementation with macular carotenoids reduces psychological stress, serum cortisol, and sub-optimal symptoms of physical and emotional health in young adults. Nutr Neurosci 15:1–11 Stringham NT, Holmes PV, Stringham JM (2017) Supplementation with macular carotenoids reduces psychological stress, serum cortisol, and sub-optimal symptoms of physical and emotional health in young adults. Nutr Neurosci 15:1–11
go back to reference Vishwanathan R, Schalch W, Johnson EJ (2016) Macular pigment carotenoids in the retina and occipital cortex are related in humans. Nutr Neurosci 19(3):95–101CrossRefPubMed Vishwanathan R, Schalch W, Johnson EJ (2016) Macular pigment carotenoids in the retina and occipital cortex are related in humans. Nutr Neurosci 19(3):95–101CrossRefPubMed
go back to reference Wang J, Duan P, Cui Y, Li Q, Shi Y (2016) Geniposide alleviates depression-like behavior via enhancing BDNF expression in hippocampus of streptozotocin-evoked mice. Metab Brain Dis 31(5):1113–1122CrossRefPubMed Wang J, Duan P, Cui Y, Li Q, Shi Y (2016) Geniposide alleviates depression-like behavior via enhancing BDNF expression in hippocampus of streptozotocin-evoked mice. Metab Brain Dis 31(5):1113–1122CrossRefPubMed
go back to reference Wayhs CA, Mescka CP, Vanzin CS, Ribas GS, Guerreiro G, Nin MS et al (2013) Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior. Metab Brain Dis 28(4):563–570CrossRefPubMed Wayhs CA, Mescka CP, Vanzin CS, Ribas GS, Guerreiro G, Nin MS et al (2013) Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior. Metab Brain Dis 28(4):563–570CrossRefPubMed
go back to reference Wu B, Wei Y, Wang Y, Su T, Zhou L, Liu Y et al (2015) Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice. Oncotarget 6(33):34128–34142CrossRefPubMedPubMedCentral Wu B, Wei Y, Wang Y, Su T, Zhou L, Liu Y et al (2015) Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice. Oncotarget 6(33):34128–34142CrossRefPubMedPubMedCentral
go back to reference Xiao J, Wang J, Xing F, Han T, Jiao R, Liong EC et al (2014) Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway. PLoS One 9(4):e95214CrossRefPubMedPubMedCentral Xiao J, Wang J, Xing F, Han T, Jiao R, Liong EC et al (2014) Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway. PLoS One 9(4):e95214CrossRefPubMedPubMedCentral
go back to reference Ying C, Zhang F, Zhou X, Hu X, Chen J, Wen X et al (2015) Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus. Cell Mol Neurobiol 35(7):1027–1037CrossRefPubMed Ying C, Zhang F, Zhou X, Hu X, Chen J, Wen X et al (2015) Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus. Cell Mol Neurobiol 35(7):1027–1037CrossRefPubMed
go back to reference Ying C, Chen L, Wang S, Mao Y, Ling H, Li W et al (2017) Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway. Biomed Pharmacother 90:796–805CrossRefPubMed Ying C, Chen L, Wang S, Mao Y, Ling H, Li W et al (2017) Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway. Biomed Pharmacother 90:796–805CrossRefPubMed
go back to reference Zhou X, Zhang F, Hu X, Chen J, Tang R, Zheng K et al (2017a) Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice. Brain Res 1657:262–268CrossRefPubMed Zhou X, Zhang F, Hu X, Chen J, Tang R, Zheng K et al (2017a) Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice. Brain Res 1657:262–268CrossRefPubMed
go back to reference Zhou X, Wang S, Ding X, Qin L, Mao Y, Chen L et al (2017b) Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway. Brain Res Bull 132:190–198CrossRefPubMed Zhou X, Wang S, Ding X, Qin L, Mao Y, Chen L et al (2017b) Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway. Brain Res Bull 132:190–198CrossRefPubMed
go back to reference Zhou X, Zhang F, Ying C, Chen J, Chen L, Dong J et al (2017c) Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway. Behav Brain Res 322(Pt A):70–82CrossRefPubMed Zhou X, Zhang F, Ying C, Chen J, Chen L, Dong J et al (2017c) Inhibition of iNOS alleviates cognitive deficits and depression in diabetic mice through downregulating the NO/sGC/cGMP/PKG signal pathway. Behav Brain Res 322(Pt A):70–82CrossRefPubMed
Metadata
Title
Zeaxanthin improved diabetes-induced anxiety and depression through inhibiting inflammation in hippocampus
Authors
Xiaoyan Zhou
Tian Gan
Gaoxia Fang
Shangshang Wang
Yizhen Mao
Changjiang Ying
Publication date
01-06-2018
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 3/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0179-x

Other articles of this Issue 3/2018

Metabolic Brain Disease 3/2018 Go to the issue